Erdur, A.C.* et al. Improving risk assessment of local failure in brain metastases patients using vision transformers - A multicentric development and validation study. Radiother. Oncol. 210:111031 (2025)
Erdur, A.C.* & Peeken, J.C. Response to commentary on "Improving risk assessment of local failure in brain metastases patients using vision transformers - A multicentric development and validation study" by Zhang et al. Radiother. Oncol., 111233 (2025)
Zamboglou, C.* et al. oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus. Radiother. Oncol. 210:111039 (2025)
Kern, J.* et al. Identification of the unfolded protein response pathway as target for radiosensitization in pancreatic cancer. Radiother. Oncol. 191:110059 (2024)
Peeken, J.C. et al. Development and benchmarking of a Deep Learning-based MRI-guided gross tumor segmentation algorithm for Radiomics analyses in extremity soft tissue sarcomas. Radiother. Oncol. 197:110338 (2024)
Buchner, J.A.* et al. Identifying core MRI sequences for reliable automatic brain metastasis segmentation. Radiother. Oncol. 188:109901 (2023)
Linge, A.* et al. The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts. Radiother. Oncol. 191:110055 (2023)
Scharl, S.* et al. Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study. Radiother. Oncol. 184:109678 (2023)
Buchner, J.A.* et al. Development and external validation of an MRI-based neural network for brain metastasis segmentation in the AURORA multicenter study. Radiother. Oncol. 178:109425 (2022)
Diehl, C. et al. nTMS-derived DTI-based motor fiber tracking in radiotherapy treatment planning of high-grade gliomas for avoidance of motor structures. Radiother. Oncol. 171, 189-197 (2022)
Löck, S.* et al. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - hypothesis generation on a multicentre cohort of the DKTK-ROG. Radiother. Oncol. 169, 8-14 (2022)
Patil, S.* et al. Analyses of molecular subtypes and their association to mechanisms ofradioresistance in patients with HPV-negative HNSCC treated bypostoperative radiochemotherapy. Radiother. Oncol. 167, 300-307 (2022)
Patil, S.* et al. Development and validation of a 6-gene signature for the prognosis of loco-regional control in patients with HPV-negative locally advanced HNSCC treated by postoperative radio(chemo)therapy. Radiother. Oncol. 171, 91-100 (2022)
Combs, S.E. et al. ESTRO ACROP guideline for target volume delineation of skull base tumors. Radiother. Oncol. 156, 80-94 (2021)
Nguyen, L. et al. Impact of DNA repair and reactive oxygen species levels on radioresistance in pancreatic cancer. Radiother. Oncol. 159, 265-276 (2021)
Peeken, J.C. et al. MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy. Radiother. Oncol. 164, 73-82 (2021)
Borm, K.J.* et al. Irradiation of regional lymph node areas in breast cancer - Dose evaluation according to the Z0011, AMAROS, EORTC 10981-22023 and MA-20 field design. Radiother. Oncol. 142, 195-201 (2020)
Akhgar, J.* ; Peeken, J.C. ; Pigorsch, S.U.* & Combs, S.E. Response prediction of palliative radiotherapy to painful spinal bone metastases. Radiother. Oncol. 133, S879-S880 (2019)
Bartzsch, S. Compact microbeam sources and microbeam treatment planning. Radiother. Oncol. 133, S176-S177 (2019)
Bierbaumer, D.* et al. Impact of diabetes on outcome and toxicity of neoadjuvant (chemo)radiation for rectal cancer. Radiother. Oncol. 133, S794-S795 (2019)
Bierbaumer, D.* et al. Impact of diabetes on outcome and toxicity of chemoradiation for esophageal squamous cell carcinoma. Radiother. Oncol. 133, S780-S780 (2019)
Brunner, T.B.* et al. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. Radiother. Oncol. 132, 42-47 (2019)
Dapper, H.* et al. A PET-based patterns of failure analysis in the context of contouring guidelines in anal cancer. Radiother. Oncol. 133, S193-S194 (2019)
Diehl, C.D.* et al. Application of presurgical navigated transcranial magnetic stimulation motor mapping for adjuvant radiotherapy planning in patients with high-grade gliomas. Radiother. Oncol. 138, 30-37 (2019)
Gerhardt, A.S.* et al. Influence of rotational setup errors on dose in target and organs at risk in cranial radiotherapy. Radiother. Oncol. 133, S1210-S1211 (2019)
Hirmer, E. et al. The interaction between miR-221 overexpression and radiosensitivity in mamma carcinoma cell lines. Radiother. Oncol. 133, S603-S604 (2019)
Hombrink, G. ; Wilkens, J.J.* ; Combs, S.E. & Bartzsch, S. Microcavities in the lung affect the dose distribution in microbeam radiation therapy. Radiother. Oncol. 133, S47-S48 (2019)
Kessel, K.A. et al. Influence of PET-imaging during treatment planning on outcome in meningioma patients. Radiother. Oncol. 133, S690-S691 (2019)
Klapproth, A.* et al. MC simulations on the dose enhancement effect of antibody conjugated AuNPs in targeted radiotherapy. Radiother. Oncol. 133, S1147-S1148 (2019)
Kundrat, P. et al. Minimum breast distance largely explains individual variability in doses to contralateral breast from breast-cancer radiotherapy. Radiother. Oncol. 131, 186-191 (2019)
Linge, A.* et al. TCGA molecular subclassification is prognostic for LRC of HNSCC after postoperative RCTx. Radiother. Oncol. 133, S196-S196 (2019)
Oechsner, M.* et al. Gated treatment of left-sided breast cancer: Evaluation of lung movement, irradiated volume and mass. Radiother. Oncol. 133, S715-S715 (2019)
Peeken, J.C. et al. CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy. Radiother. Oncol. 135, 187-196 (2019)
Peeken, J.C. et al. Deep learning derived tumor infiltration maps for personalized target definition in Glioblastoma radiotherapy. Radiother. Oncol. 138, 166-172 (2019)
Porth, A.* et al. Analysis of Chromosomal Aberrations by FISH in FaDu tumor cells after in vivo X-ray MRT irradiation. Radiother. Oncol. 133, S1198-S1198 (2019)
Schmal, Z.* et al. DNA damage accumulation during fractionated low-dose radiation compromises hippocampal neurogenesis. Radiother. Oncol. 137, 45-54 (2019)
Schmid, T. et al. Biological interaction of a static magnetic field (SMF) with ionizing irradiation. Radiother. Oncol. 133, S600-S601 (2019)
Simonetto, C. et al. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiother. Oncol. 131, 202-207 (2019)
Starke, S.* et al. Deep-learning based estimation of loco-regional control for patients with locally advanced HNSCC. Radiother. Oncol. 133, S254-S255 (2019)
Treibel, F. ; Wilkens, J.J.* ; Bartzsch, S. & Combs, S.E. An optimized compact microbeam source for preclinical studies. Radiother. Oncol. 133, S56-S57 (2019)
Brunner, T.* et al. Dose of stereotactic radiotherapy, local control and overall survival in cholangiocarcinoma. Radiother. Oncol. 127, S85-S86 (2018)
Combs, S.E. et al. Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology. Radiother. Oncol. 127, 274-279 (2018)
Dapper, H.* ; Oechsner, M.* ; Münch, S.* ; Combs, S.E. & Habermehl, D. DVH- and NTCP-based dosimetric comparison of different cranial margins for VMAT of rectal cancer. Radiother. Oncol. 127, S802-S803 (2018)
De-Colle, C.* et al. SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy. Radiother. Oncol. 126, 125-131 (2018)
Forster, C.* ; Schilling, D. ; Wank, M. ; Schmid, T.E. & Combs, S.E. Effects of the proteasome inhibitor bortezomib on radiosensitivity of glioblastoma cells. Radiother. Oncol. 127, S1281-S1282 (2018)
Gora, T.* et al. Detection of radiation induced lung fibrosis using x-ray dark-field imaging in a murine model. Radiother. Oncol. 127, E581-E582 (2018)
Hofmeister, A.* et al. Reduction of lung dose during stereotactic radiation of lung tumors using respiratory gating. Radiother. Oncol. 127, S758-S759 (2018)
Kessel, K.A. et al. Tomotherapy of pediatric sarcomas: Outcome and toxicity rates. Radiother. Oncol. 127, S610-S611 (2018)
Kessel, K.A. et al. Cancer Clinical Trials - survey evaluating patient participation and attitude in an Oncology Center. Radiother. Oncol. 127, S50-S50 (2018)
Kessel, K.A. ; Bihoi, G.A.* ; Oechsner, M.* ; Duma, M.N.* & Combs, S.E. Influence of dose applied to cochlea during RT of vestibular schwannoma and its effect on hearing. Radiother. Oncol. 127, S636-S637 (2018)
Klymenko, O. et al. HNSCC derived cell lines and subclones differ in genomic copy number changes and radiation response. Radiother. Oncol. 127, S1266-S1267 (2018)
Linge, A.* et al. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC. Radiother. Oncol. 127, 27-35 (2018)
Martin, F.* et al. Downregulation of ALDH1A1 reduces radioresistance and migration of glioblastoma cells. Radiother. Oncol. 127, S1283-S1283 (2018)
Mueller, B.S.* et al. Dosimetric impact of stabilizing spinal implants in proton therapy: Titanium vs. carbon systems. Radiother. Oncol. 127, S1052-S1053 (2018)
Schilling, D. ; Herold, B.* ; Combs, S.E. & Schmid, T.E. Selenium does not affect radiosensitivity of human breast cancer cell lines. Radiother. Oncol. 127, S1271-S1271 (2018)
Schmidt, A.A.* ; Kessel, K.A.* ; Duma, M.N.* & Combs, S.E. 15 years of cerebral stereotactic radiotherapy at the Klinikum rechts der Isar, Munich. Radiother. Oncol. 127, S659-S660 (2018)
Schoetz, U.* et al. Prognostic biomarkers and targets for personalization of radiotherapy of HNSCC: CD44v6. Radiother. Oncol. 127, S251-S251 (2018)
Adeberg, S.* et al. Sequential proton boost after standard chemoradiation for high-grade glioma. Radiother. Oncol. 125, 266-272 (2017)
Friedland, W. & Kundrát, P. Stochastic multi-scale modelling of biological effects induced by ionizing radiation. In: (El Naqa, I [Ed.]: A guide to outcome modeling in radiotherapy and oncology). 2017. 147-180 (Radiother. Oncol.)
Hofmaier, J.* et al. Multi-criterial patient positioning based on dose recalculation on scatter-corrected CBCT images. Radiother. Oncol. 125, 464-469 (2017)
Linge, A.* et al. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother. Oncol. 121, 364-373 (2016)
Niyazi, M.* et al. ESTRO-ACROP guideline "target delineation of glioblastomas". Radiother. Oncol. 118, 35-42 (2016)
Sage, E.K.* et al. Comparative analysis of the effects of radiotherapy versus radiotherapy after adjuvant chemotherapy on the composition of lymphocyte subpopulations in breast cancer patients. Radiother. Oncol. 118, 176-180 (2016)
Chaachouay, H. et al. AMPK-independent autophagy promotes radioresistance of human tumor cells under clinical relevant hypoxia in vitro. Radiother. Oncol. 116, 409-416 (2015)
Combs, S.E.* et al. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers. Radiother. Oncol. 114, 378-383 (2015)
Sievert, W. et al. Late proliferating and inflammatory effects on murine microvascular heart and lung endothelial cells after irradiation. Radiother. Oncol. 117, 376-381 (2015)
Barjaktarovic, Z. et al. Ionising radiation induces persistent alterations in the cardiac mitochondrial function of C57BL/6 mice 40 weeks after local heart exposure. Radiother. Oncol. 106, 404-410 (2013)
Schildkopf, P.* et al. Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother. Oncol. 101, 109-115 (2011)
Stangl, S. et al. Detection of irradiation-induced, membrane heat shock protein 70 (Hsp70) in mouse tumors using Hsp70 Fab fragment. Radiother. Oncol. 99, 313-316 (2011)
Ballarini, F.* et al. Role of DNA organisation and environmental scavenging capacity in the evolution of radiobiological damage: Models and simulations. Radiother. Oncol. 73, S170-S172 (2005)
Schultz-Hector, S. et al. Complications of combined intraoperative radiation (IORT) and external radiation (ERT) of the upper abdomen: An experimental model. Radiother. Oncol. 38, 205-214 (1996)
Kummermehr, J. & Trott, K.R. Chronic radiation damage in the rat rectum: An analysis of tiie influences of fractionation, time and volume [1]. Radiother. Oncol. 33, 91-92 (1994)
Dörr, W. ; Breitner, A. & Kummermehr, J. Capacity and Kinetics of SLD Repair in Mouse Tongue Epithelium. Radiother. Oncol. 27, 36-45 (1993)
Dörr, W. ; Hirler, E. & Hönig, M. Response of mouse tongue epithelium to single doses of bleomycin and radiation. Radiother. Oncol. 27, 237-244 (1993)
Dörr, W. ; Breitner, A. & Kummermehr, J.C. Capacity and kinetics of SLD repair in mouse tongue epithelium. Radiother. Oncol. 27, 36-45 (1993)
Schultz-Hector, S. ; Sund, M. & Thames, H.D. Fractionation Response and Repair Kinetics of Radiation-induced Heart Failure in the Rat. Radiother. Oncol. 123, 33-40 (1992)
Trott, K.R.* & Kummermehr, J.C. Accelerated repopulation in tumours and normal tissues. Radiother. Oncol. 22, 159-160 (1991)
Dörr, W. & Kummermehr, J. Accelerated Repopulation of Mouse Tongue Epithelium During Fractionated Irradiations or Following Single Doses. Radiother. Oncol. 17, 249-259 (1990)
Dörr, W. & Kummermehr, J.C. Accelerated repopulation of mouse tongue epithelium during fractionated irradiations or following single doses. Radiother. Oncol. 17, 249-259 (1990)
Guttenberger, R. ; Kummermehr, J. & Chmelevsky, D. Kinetics of Recovery from Sublethal Radiation Damage in four Murine Tumors. Radiother. Oncol. 18, 79-88 (1990)
Guttenberger, R. ; Kummermehr, J.C. & Chmelevsky, D. Kinetics of recovery from sublethal radiation damage in four murine tumors. Radiother. Oncol. 18, 79-88 (1990)
Kolb, H.-J. et al. Dose Rate and Fractionation of Total Body Irradiation in Dogs Short and Long Term Effects. Radiother. Oncol. Suppl.1, 51-59 (1990)
Kolb1, H.J.* et al. Dose rate and fractionation of total body irradiation in dogs: Short and long term effects. Radiother. Oncol. 18, 51-59 (1990)
Frankenberg-Schwager, M. Review of Repair Kinetics for DNA Damage induced in Eukaryotic Cells in Vitro by Ionizing Radiation. Radiother. Oncol. 14, 307-320 (1989)
Frankenberg-Schwager, M. Review of repair kinetics for DNA damage induced in eukaryotic cells in vitro by ionizing radiation. Radiother. Oncol. 14, 307-320 (1989)
Guttenberger, R. Reply to: Analysis of the effects of fractionated irradiation to the rat heart (by E. van Rongen). Radiother. Oncol. 10, 329-330 (1987)
Knowles, J.F. & Trott, K.-R. Experimental Irradiation of the Rat Ureter: The Effects of Field Size and the Presence of Contrast Medium on Incidence and Latency of Hydronephrosis. Radiother. Oncol. 10, 59-66 (1987)
Ziegler, W.H. ; Birkenfeld, P. & Trott, K.R.* The effect of combined treatment of HeLa cells with actinomycin D and radiation upon survival and recovery from radiation damage. Radiother. Oncol. 10, 141-148 (1987)
Ziegler, W.H. & Kopp, J.M. The effect of combined treatment of HeLa cells with cisplatin and irradiation upon survival and recovery from radiation damage. Radiother. Oncol. 8, 71-78 (1987)
Breiter, N. & Trott, K.R. Chronic radiation damage in the rectum of the rat after protracted fractionated irradiation. Radiother. Oncol. 7, 155-163 (1986)
Lauk, S. Strain differences in the radiation response of the rat heart. Radiother. Oncol. 5, 333-335 (1986)
Lindenberger, J.* ; Hermeking, H.* ; Kummermehr, J.C. & Denekamp, J.* Response of human tumour xenografts to fractionated X-irradiation. Radiother. Oncol. 6, 15-27 (1986)
Trott, K.-R. & Kummermehr, J. What is Known About Tumour Proliferation Rates to Choose Between Accelerated Fractionation of Hyperfractionation? Radiother. Oncol. 3, 1-9 (1985)
Trott, K.R. ; Maciejewski, B.S. ; Preuss-Bayer, G. & Skołyszewski, J.F. Dose-response curve and split-dose recovery in human skin cancer. Radiother. Oncol. 2, 123-129 (1984)